Bright Minds Biosciences Inc.
DRUG
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.70M | -14.24M | -8.78M | -6.38M | -2.42M |
| Total Depreciation and Amortization | 52.20K | 53.70K | 54.90K | 91.70K | 58.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.49M | 5.09M | 2.10M | 1.04M | -335.50K |
| Change in Net Operating Assets | 889.10K | -220.40K | 409.60K | -387.10K | -224.90K |
| Cash from Operations | -14.27M | -9.31M | -6.21M | -5.63M | -2.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -104.00K | -102.30K | -100.10K | -97.90K | -94.30K |
| Issuance of Common Stock | 293.46M | 50.42M | 86.03M | 49.82M | 49.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.20M | -3.40M | -360.20K | 2.51M | 2.51M |
| Cash from Financing | 198.07M | 33.94M | 61.51M | 37.30M | 37.30M |
| Foreign Exchange rate Adjustments | -948.10K | -1.98M | 211.00K | 607.30K | 1.19M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 182.85M | 22.64M | 55.51M | 32.28M | 35.57M |